Race-Based eGFR Kidney Transplant Delay Investigation

Migliaccio & Rathod LLP is investigating whether race-based eGFR kidney function calculations were used in hospitals and transplant centers to improperly delay kidney transplant eligibility for Black patients.

For many years, many healthcare providers used an estimated glomerular filtration rate (“eGFR”) formula that automatically increased kidney function estimates for patients identified as Black. Because higher eGFR values made kidney function appear better than it actually was, some Black patients may have been referred to transplant specialists later, placed on kidney transplant waiting lists later, or experienced delays in receiving life-saving treatment.

National transplant policies now require transplant centers to identify affected patients and restore lost waiting time where appropriate.

What Patients Report

Patients report:

  • Learning that race-based kidney function calculations delayed transplant eligibility.
  • Being referred to transplant specialists later than expected.
  • Receiving delayed placement on transplant waiting lists.
  • Never being notified that waiting time should be recalculated.
  • Remaining uncertain whether corrected wait time was restored.
  • Progression of kidney disease while awaiting transplantation.

Why Patients Should Be Concerned

Kidney transplant waiting time is one of the most important factors affecting when a patient receives a donor organ. Even months of lost waiting time may significantly delay transplantation.

Race-based eGFR equations have largely been replaced with race-neutral formulas because medical organizations concluded that race is a social construct rather than a biological characteristic that should determine kidney function estimates. This investigation seeks to determine whether hospitals properly corrected transplant waiting times and notified affected patients.

Potential Claims May Include

  • Healthcare Discrimination
  • Violation of Section 1557 of the Affordable Care Act
  • Violation of Title VI of the Civil Rights Act
  • Consumer Protection
  • Negligence
  • Declaratory and Injunctive Relief

Signs You May Be Affected

You may be affected if:

  • You are a Black patient diagnosed with chronic kidney disease.
  • Your kidney disease was evaluated before January 2023.
  • You were told your kidney function was not low enough for transplant listing.
  • Your transplant evaluation occurred later than expected.
  • You have not received notice that your waiting time was reviewed.
  • You believe race-based calculations delayed your transplant care.

If you have encountered these issues, we would like to hear from you. Please complete the contact form on this page, send us an email at [email protected], or give us a call at (202) 470-3520.

    The following will ask for your contact information so that we may reach you to talk about potential claims. This information is for our records only and will not be shared. By continuing, you consent to the collection of this information for these limited purposes.

    When did you first enter into the agreement (month and year)? Do you still have an agreement with the company?

    Why do you believe that the agreement is unfair, deceptive, and/or unlawful?


    Would you like to join our newsletter to receive notifications about other investigations we're looking into, as well as updates on ongoing cases?

    By submitting this form, you consent to receive marketing, updates, and informative SMS messages from Migliaccio & Rathod LLP at the email and/or phone number provided. Message & data rates may apply. Message frequency varies. Unsubscribe at any time by replying STOP or Reply HELP for help. Privacy Policy